Local consolidative therapy extends survival in metastatic NSCLC with oligoresidual disease following first-line immunotherapy, irrespective of PD-L1 expression.Xie W, Yan M, Wen F, et al. Sci Rep. 2025 Oct 21;15(1):36765. doi: 10.1038/s41598-025-20679-2. PMID: 41120489; PMCID: PMC12540777. 【概要】・一次免…